Aqr Capital Management LLC Chemo Centryx, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $245,288 - $573,115	11,064 Added 126.1%	19,838 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $134,768 - $241,372	8,774 New	8,774 $217,000
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $283,163 - $1.5 Million	-29,527 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $50,520 - $69,768	-1,020 Reduced 3.34%	29,527 $1.51 Million
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $209,979 - $289,571	-4,444 Reduced 12.7%	30,547 $1.89 Million
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $295,852 - $393,767	-6,383 Reduced 15.43%	34,991 $1.92 Million
Q2 2020 Aug 17, 2020	SELL	$38.58 - $65.07 $87,730 - $147,969	-2,274 Reduced 5.21%	41,374 $2.38 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $1.24 Million - $1.93 Million	38,036 Added 677.76%	43,648 $1.75 Million
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $38,217 - $221,954	5,612 New	5,612 $222,000
Q3 2019 Nov 14, 2019	SELL	$6.47 - $8.96 $88,030 - $121,909	-13,606 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.31 - $14.85 $72,778 - $130,056	-8,758 Reduced 39.16%	13,606 $127,000
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $237,505 - $312,648	22,364 New	22,364 $295,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.